Metabolic syndrome prevention & management

The role of inflammation in the development of metabolic syndrome

• Rheumatic diseases are considered to be autoimmune diseases and produce chronic inflammatory injury to multiple organs, mainly joints.
• Several inflammatory mediators, such as, cytokines or tumor necrosis factor (TNF), are produced in response to inflammation.
• These inflammatory mediators have been reported to induce metabolic syndrome by increasing insulin resistance and modulating insulin sensitivity and blood lipid profiles.

Strategies to manage inflammation

Taking medications

• The most important strategy to manage inflammation in rheumatic disease is taking medications as prescribed.

Monitoring of serum inflammatory indices

• Monitor inflammatory indices regularly with routine blood tests.